Skip to main content

Table 1 The composition and characteristics of the tested niosomal formulations

From: Niosomes of active Fumaria officinalis phytochemicals: antidiabetic, antineuropathic, anti-inflammatory, and possible mechanisms of action

Code

Compositiona

Weight ratio

EE (%)

Zeta potential (mV)

Z-average (nm)

PDIb

Nio1

S:CH

1:1

91.25 ± 2.80

− 53.06 ± 2.40

90.60 ± 1.90

0.30 ± 0.01

Nio2

S:CH

2:1

94.65 ± 3.33

− 56.75 ± 2.60

96.56 ± 1.87

0.34 ± 0.02

Nio3

S:CH

3:1

92.56 ± 4.21

− 58.10 ± 3.10

97.60 ± 1.55

0.36 ± 0.01

Nio4

S:B

1:1

96.70 ± 2.30

− 67.80 ± 3.40

93.56 ± 2.22

0.31 ± 0.01

Nio5

S:B

2:1

98.22 ± 1.44

− 65.38 ± 3.20

94.66 ± 2.34

0.33 ± 0.02

Nio6

S:B

3:1

93.55 ± 1.99

− 58.50 ± 3.00

98.7 ± 1.22

0.36 ± 0.01

Placebo I

S:CH

3:1

–

− 25.70 ± 2.45

86.66 ± 1.11

0.28 ± 0.02

Placebo II

S:B

3:1

–

− 24.60 ± 2.68

84.99 ± 1.33

0.27 ± 0.01

  1. aS Span 60, CH cholesterol, B Brij 52
  2. bPDI poly-dispersity index